The stock of Staar Surgical Co. (STAA) has gone down by -8.21% for the week, with a -21.49% drop in the past month and a 38.30% rise in the past quarter. The volatility ratio for the week is 5.39%, and the volatility levels for the past 30 days are 4.27% for STAA. The simple moving average for the last 20 days is -13.00% for STAA stock, with a simple moving average of 6.53% for the last 200 days.
Is It Worth Investing in Staar Surgical Co. (NASDAQ: STAA) Right Now?
Staar Surgical Co. (NASDAQ: STAA) has a price-to-earnings ratio of 132.62x that is above its average ratio. Additionally, the 36-month beta value for STAA is 0.68. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for STAA is 48.75M and currently, short sellers hold a 10.00% ratio of that float. The average trading volume of STAA on May 09, 2024 was 685.88K shares.
STAA) stock’s latest price update
The stock of Staar Surgical Co. (NASDAQ: STAA) has decreased by -12.07 when compared to last closing price of 46.65. Despite this, the company has experienced a -8.21% fall in its stock price over the last five trading sessions. Seeking Alpha reported 2024-05-07 that STAAR Surgical Company (NASDAQ:STAA ) Q1 2024 Results Conference Call May 7, 2024 4:15 PM ET Company Participants Brian Moore – VP, IR Tom Frinzi – President, CEO Patrick Williams – CFO Conference Call Participants Margaret Kaczor – William Blair Tom Stephan – Stifel Patrick Wood – Morgan Stanley Young Li – Jefferies John Young – Canaccord Anthony Petrone – Mizuho George Sellers – Stephens Operator Greetings. Welcome to the STAAR Surgical First Quarter 2024 Earnings Call and Webcast.
Analysts’ Opinion of STAA
Many brokerage firms have already submitted their reports for STAA stocks, with Stifel repeating the rating for STAA by listing it as a “Buy.” The predicted price for STAA in the upcoming period, according to Stifel is $50 based on the research report published on March 11, 2024 of the current year 2024.
Morgan Stanley gave a rating of “Equal-Weight” to STAA, setting the target price at $35 in the report published on December 04th of the previous year.
STAA Trading at -1.94% from the 50-Day Moving Average
After a stumble in the market that brought STAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.92% of loss for the given period.
Volatility was left at 4.27%, however, over the last 30 days, the volatility rate increased by 5.39%, as shares sank -19.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.52% upper at present.
During the last 5 trading sessions, STAA fell by -8.21%, which changed the moving average for the period of 200-days by -28.93% in comparison to the 20-day moving average, which settled at $46.65. In addition, Staar Surgical Co. saw 31.43% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STAA starting from WEISNER AIMEE S, who purchase 1,750 shares at the price of $38.11 back on Mar 14 ’24. After this action, WEISNER AIMEE S now owns 10,864 shares of Staar Surgical Co., valued at $66,692 using the latest closing price.
BROADWOOD PARTNERS, L.P., the 10% Owner of Staar Surgical Co., purchase 4,042 shares at $27.11 during a trade that took place back on Jan 08 ’24, which means that BROADWOOD PARTNERS, L.P. is holding 10,768,430 shares at $109,570 based on the most recent closing price.
Stock Fundamentals for STAA
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.79 for the gross margin
The net margin for Staar Surgical Co. stands at 0.05. The total capital return value is set at 0.05. Equity return is now at value 4.18, with 3.36 for asset returns.
Based on Staar Surgical Co. (STAA), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 1.16. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -12.63.
Currently, EBITDA for the company is 33.22 million with net debt to EBITDA at -6.19. When we switch over and look at the enterprise to sales, we see a ratio of 5.6. The receivables turnover for the company is 5.05for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.84.
Conclusion
In conclusion, Staar Surgical Co. (STAA) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
